DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fesoterodine
Fesoterodine
Download
Urinary Antispasmodics TCO 02.2018
Printed Formulary Catalog Basic
Toviaz) Reference Number: ERX.ST.16 Effective Date: 09.01.17 Last Review Date: 08.17 Line of Business: Commercial [Prescription Drug Plan] Revision Log
Fesoterodine
Supplemental Table 1: Patient Characteristics, Interventions and Definitions/Variables of Persistence, Adherence and Discontinuation Reported in the Studies
Drug Benefit Council (DBC) Recommendation and Reasons for Recommendation FINAL
Pharmacological Treatment of Urinary Incontinence
PREZCOBIX-Pi.Pdf
Toviaz, INN-Fesoterodine Fumarate
Therapeutic Class Overview Urinary Antispasmodics
Product Monograph Including Patient Medication Information
A Guide to the Administration of Medicines in the Perioperative
Urinary Incontinence in Dementia Service Notifications Recent Incidents with Ethinylestradiol Managed Entry Decisions
Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
Maintenance Drug List
Prior Authorization PDL Implementation Schedule
Brand Generic Guide
Top View
Overactive Bladder Agents Reference Number: CP.PMN.198 Effective Date: 05.01.16 Last Review Date: 08.20 Revision Log Line of Business: Commercial, HIM, Medicaid
Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
Oral Medicines for the Management of Urinary Incontinence, Frequency & Overactive Bladder
Use of Overactive Bladder Medications in the Adult Population Of
Safety and Tolerability Profiles of Anticholinergic Agents Used for the Treatment of Overactive Bladder Michael G
Bladder Relaxant Preparations
Pharmacologic Treatment of Overactive Bladder
Contraindications
Ep 2554184 B1
Green Chemistry
Where Will I Have My Urodynamic Test? the Test Is Carried out in CQMI
Neurologic Urinary and Faecal Incontinence
NYSDOH Uninsured Care Programs Covered Services and ADAP
Urinary Incontinence
Preferred Drug List (PDL)
Urinary Frequency Tom Kincer, MD Program Director Clinical Professor of Medicine Montgomery Family Medicine Residency
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
Toviaz (Fesoterodine)
Benefit-Risk Evaluation of Tolterodine 4 Mg and Fesoterodine Fixed And
372 Fesoterodine Is Cost-Effective Relative To
Contents Contents Regulatory Matters Regulatory Matters Safety of Medicines Safety of Medicines Signal Feature Feature
Overactive Bladder in an Integrated Delivery System: a Longitudinal Cohort Study Jeffrey A
Flavoxate: Present and Future
Supplementary File 2: Characteristics of Included Ads
Supplemental Table 2. Summary of Adherence and Persistence Rates and Determinants
Recommendations of the SEC (Reproductive & Urology)
24 Comparison of Receptor Binding Characteristics of Commonly Used Muscarinic Antagonists in Human Bladder Detrusor and Mucosa
Orange Book Cumulative Supplement 7 July 2021
Pfizer Clinical Trial for Fesoterodine Fumarate (Toviaz®)
Medications for Symptoms of an Overactive Bladder
Scientific and Regulatory Reasons for Delay and Denial of FDA Approval of Initial Applications for New Drugs, 2000-2012
Fesoterodine Is Cost-Effective Relative to Tolterodine And
Therapeutic Class Overview Urinary Antispasmodics
FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
Overactive Bladder ST
Trial of Stopping Your Overactive Bladder Drug
Fesoterodine Fumarate Written Request
OAB) Syndrome
Treatment of Autonomic Dysfunction in Parkinson Disease and Other Synucleinopathies
North Dakota Medicaid Therapeutic Duplication Edits
Package Leaflet: Information for the User TOVIAZ 4 Mg Prolonged
Presumptively Compensable Expenses
Bladder Dysfunction in Parkinson's Disease
Metabolic N-Dealkylation and N-Oxidation As Elucidators of the Role of Alkylamino Moieties in Drugs Acting at Various Receptors
Informationen Zur Zweckmäßigen Vergleichstherapie
Table of Medications That Increase Fall Risk
Comparison of Solifenacin and Fesoterodine in Treatment of Overactive Bladder
Part I Introduction to Series, Methods, and Tolterodine Vs
Enablex Gemtesa and Toviaz
Fesoterodine Fumarate States That Patients Dutasterid; Dutasterida; Dutastéride; Dutasteridum; GG-745; Emepronio, Carragenato De
Preferred Drug List
Treatment of Overactive Bladder
Effective 07-01-2021) the Florida Medicaid Preferred Drug List (PDL
Medications for Non-Motor Symptoms